These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 14525798)
1. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis. Fan VS; Bryson CL; Curtis JR; Fihn SD; Bridevaux PO; McDonell MB; Au DH Am J Respir Crit Care Med; 2003 Dec; 168(12):1488-94. PubMed ID: 14525798 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Suissa S Am J Respir Crit Care Med; 2003 Jul; 168(1):49-53. PubMed ID: 12663327 [TBL] [Abstract][Full Text] [Related]
3. Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias. Kiri VA; Pride NB; Soriano JB; Vestbo J Am J Respir Crit Care Med; 2005 Aug; 172(4):460-4. PubMed ID: 15901610 [TBL] [Abstract][Full Text] [Related]
4. [Do inhaled corticosteroids reduce mortality in chronic obstructive pulmonary disease?]. Bridevaux PO; Leuenberger P Rev Med Suisse; 2005 Nov; 1(41):2673-4, 2677-9. PubMed ID: 16355882 [TBL] [Abstract][Full Text] [Related]
6. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304 [TBL] [Abstract][Full Text] [Related]
7. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease. Gershon AS; Campitelli MA; Croxford R; Stanbrook MB; To T; Upshur R; Stephenson AL; Stukel TA JAMA; 2014 Sep; 312(11):1114-21. PubMed ID: 25226477 [TBL] [Abstract][Full Text] [Related]
8. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Ernst P; Gonzalez AV; Brassard P; Suissa S Am J Respir Crit Care Med; 2007 Jul; 176(2):162-6. PubMed ID: 17400730 [TBL] [Abstract][Full Text] [Related]
9. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Baker WL; Baker EL; Coleman CI Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942 [TBL] [Abstract][Full Text] [Related]
10. Effect of corticosteroids on exacerbations of asthma and chronic obstructive pulmonary disease. Calverley PM Proc Am Thorac Soc; 2004; 1(3):161-6. PubMed ID: 16113429 [TBL] [Abstract][Full Text] [Related]
11. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Sin DD; Tu JV Am J Respir Crit Care Med; 2001 Aug; 164(4):580-4. PubMed ID: 11520719 [TBL] [Abstract][Full Text] [Related]
12. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD). Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850 [TBL] [Abstract][Full Text] [Related]
13. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Singh S; Amin AV; Loke YK Arch Intern Med; 2009 Feb; 169(3):219-29. PubMed ID: 19204211 [TBL] [Abstract][Full Text] [Related]
14. Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes. Vollmer WM; Peters D; Crane B; Kelleher C; Buist AS COPD; 2007 Jun; 4(2):135-42. PubMed ID: 17530507 [TBL] [Abstract][Full Text] [Related]
15. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease. Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915 [TBL] [Abstract][Full Text] [Related]
16. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). Cecere LM; Slatore CG; Uman JE; Evans LE; Udris EM; Bryson CL; Au DH COPD; 2012 Jun; 9(3):251-8. PubMed ID: 22497533 [TBL] [Abstract][Full Text] [Related]
17. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734 [TBL] [Abstract][Full Text] [Related]
18. Inhaled Corticosteroids Particle Size and Risk of Hospitalization Due to Exacerbations and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease. A Nationwide Cohort Study. Heerfordt CK; Rønn C; Eklöf J; Sivapalan P; Harboe ZB; Hyldgaard C; Fløe A; Mathioudakis AG; Lassen MCH; Biering-Sørensen T; Jensen JS Int J Chron Obstruct Pulmon Dis; 2024; 19():2169-2179. PubMed ID: 39364225 [TBL] [Abstract][Full Text] [Related]
19. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD. Thornton Snider J; Luna Y; Wong KS; Zhang J; Chen SS; Gless PJ; Goldman DP Curr Med Res Opin; 2012 Dec; 28(12):1959-67. PubMed ID: 23098081 [TBL] [Abstract][Full Text] [Related]
20. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease. Lee TA; Schumock GT; Bartle B; Pickard AS Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]